Atlas Trials

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

Clinical trial NCT03677648 · COMPLETED

Trial details

NCT number
NCT03677648
Sponsor
Reistone Biopharma Company Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2019-05-14
Primary completion
2021-09-16
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.